Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression
Basic & Clinical Pharmacology & Toxicology · 2026-12 · 139 (6)
DOI: 10.1111/bcpt.70335 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, published online on 2026-11-20. Written by Dan Li and 8 co-authors. 42 references.
Abstract (original language)
Purpose
This study aimed to characterize heterogeneity in the anti‐hyperglycaemic response to Gegen Qinlian decoction (GQD) in type 2 diabetes mellitus (T2DM) mice and identify response‐associated candidate proteins.
Methods
T2DM mice were established by a high‐fat diet and streptozotocin. Glycaemic control and response heterogeneity were assessed using blood glucose measurements. Serum insulin concentrations and pancreatic histomorphology were used as surrogate markers of pancreatic β‐cell function (BCF). Insulin tolerance testing and an insulin‐resistant HepG2 cell model were used to assess insulin sensitivity‐related phenotypes. Candidate proteins were explored using liver transcriptomic analysis, network pharmacology and literature‐informed candidate prioritization, followed by preliminary in vivo and in vitro validation.
Results
GQD produced heterogeneous anti‐hyperglycaemic responses more closely associated with differences in insulin sensitivity‐related measurements than with surrogate BCF indices assessed. Hepatic osteopontin (OPN) expression was elevated in T2DM mice and was selectively downregulated in the exploratory strong‐responder subgroup. GQD treatment also reduced elevated OPN expression in insulin‐resistant HepG2 cells. Serum OPN concentrations were positively correlated with blood glucose, indicating an association between higher OPN levels and poorer glycaemic outcomes. Wogonin and liquiritigenin were associated with OPN downregulation and increased glucose consumption, with PPARα representing a potential yet unconfirmed mechanistic link.
Conclusion
OPN is associated with GQD treatment‐response heterogeneity and may represent a candidate response‐associated marker.
Cite
APA
Li, D., Lao, Y., Qin, Y., Li, M., Liu, Q., Qi, F., Tong, T., Liang, H., & Liu, D. (2026). Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression. Basic & Clinical Pharmacology & Toxicology, 139(6). https://doi.org/10.1111/bcpt.70335
Vancouver
Li D, Lao Y, Qin Y, Li M, Liu Q, Qi F, et al. Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression. Basic & Clinical Pharmacology & Toxicology. 2026;139(6). doi:10.1111/bcpt.70335
BibTeX
@article{Li2026,
author = {Li, Dan and Lao, Yujie and Qin, Yige and Li, Mengjie and Liu, Qi and Qi, Fei and Tong, Tao and Liang, Hao and Liu, Dongyang},
title = {Response Heterogeneity to Gegen Qinlian Decoction in Ameliorating Insulin Sensitivity Is Associated With Osteopontin Expression},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {139},
number = {6},
doi = {10.1111/bcpt.70335}
}
EUVIMED